Terns Pharmaceuticals, Inc. Common Stock (TERN) is a publicly traded Healthcare sector company. As of May 20, 2026, TERN trades at $52.95 with a market cap of $6.12B and a P/E ratio of -51.41. TERN moved +0.07% today. Year to date, TERN is +23.37%; over the trailing twelve months it is +1412.86%. Its 52-week range spans $1.87 to $53.19. Analyst consensus is neutral with an average price target of $52.97. Rallies surfaces TERN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes TERN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $52.95 |
| Market Cap | $6.12B |
| P/E Ratio | -51.41 |
| EPS | $-1.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.19 |
| 52-Week Low | $1.87 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-96.21M |
| Gross Margin | 0.00% |
6 analysts cover TERN: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $52.97.